Trademark: 79213637
Status Date
Tuesday, July 17, 2018
Registration Number
5516053
Registration Date
Tuesday, July 17, 2018
Filing Date
Tuesday, January 31, 2017
Published for Opposition
Tuesday, May 1, 2018
9 Downloadable electronic publications in the nature of books, reports, brochures, booklets, leaflets, including patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical studies, tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; computer application software for mobile devices, namely, software for providing information and interaction in the field research and development, science, clinical studies, tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention
5 Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, cognitive impairment, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; medical diagnostic agents, reagents, preparations and substances for medical purposes; pharmaceutical preparations for treatment of cognitive disorders and diseases
44 Medical services, therapeutic services and healthcare services, namely, clinical healthcare services; providing medical and healthcare information; services in the field of psychiatry and psychology and medical treatment of central nervous system diseases and disorders; medical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing medical and medicinal information in the field of diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; providing on-line medical data and analyses designed to provide patients and clients customized information, namely, regarding calculation of medical dose, diagnosis, and therapeutic issues and medical management
10 Medical diagnostic apparatus and instruments for use in diagnosing, managing, monitoring, assessing, controlling and examining symptoms, signs and effects of Alzheimer's disorder and disease, stroke, depression, cognitive impairment, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical systems, namely, medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, collecting, storing, monitoring, assessing, controlling and examining patient data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems
42 Pharmaceutical research and development; scientific and technological services, namely, research in the field of medical disorders, diseases, treatment and prevention; scientific and technological services, namely, research in the field of the central nervous system and central nervous system related disorders, diseases and pharmaceuticals; medical research and tests in the field of psychology and neurology; conducting clinical research and tests in the field of psychology and neurology; medical diagnostic research and tests namely, conducting clinical trials for others
Mar 22, 2024
Teas Change Of Correspondence Received
Mar 22, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 22, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 22, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 22, 2024
Teas Change Of Owner Address Received
Jul 17, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Nov 16, 2018
Final Decision Transaction Processed By Ib
Oct 29, 2018
Final Disposition Notice Sent To Ib
Oct 29, 2018
Final Disposition Processed
Oct 17, 2018
Final Disposition Notice Created, To Be Sent To Ib
Jul 17, 2018
Registered-Principal Register
May 1, 2018
Official Gazette Publication Confirmation E-Mailed
May 1, 2018
Published For Opposition
Apr 27, 2018
Notification Processed By Ib
Apr 11, 2018
Notification Of Possible Opposition Sent To Ib
Apr 11, 2018
Notification Of Notice Of Publication E-Mailed
Apr 11, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 26, 2018
Electronic Record Review Complete
Mar 23, 2018
On Hold - Electronic Record Review Required
Mar 20, 2018
Approved For Pub - Principal Register
Mar 20, 2018
Examiner's Amendment Entered
Mar 20, 2018
Notification Of Examiners Amendment E-Mailed
Mar 20, 2018
Examiners Amendment E-Mailed
Mar 20, 2018
Examiners Amendment -Written
Feb 23, 2018
Teas/Email Correspondence Entered
Feb 23, 2018
Correspondence Received In Law Office
Feb 22, 2018
Assigned To Lie
Feb 13, 2018
Teas Response To Office Action Received
Sep 1, 2017
Refusal Processed By Ib
Aug 15, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Aug 14, 2017
Refusal Processed By Mpu
Aug 11, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Aug 11, 2017
Application Filing Receipt Mailed
Aug 10, 2017
Non-Final Action Written
Aug 7, 2017
Assigned To Examiner
Aug 7, 2017
New Application Office Supplied Data Entered
Aug 4, 2017
Limitation From Original Application Entered
Aug 3, 2017
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
